NOVARTIS FDA Approval NDA 050574

NDA 050574

NOVARTIS

FDA Drug Application

Application #050574

Documents

Letter2005-07-26
Label2005-07-26
Label2015-04-01
Letter2004-06-17
Letter2004-06-17
Letter2004-02-27
Letter2004-02-27
Letter2006-03-23
Letter2009-11-10
Letter2010-05-06
Letter2012-09-05
Letter2013-05-07
Letter2015-04-02
Label2003-03-05
Label2003-03-05
Label2004-03-03
Label2004-03-03
Label2006-03-10
Label2009-10-14
Label2010-05-07
Label2012-08-31
Label2013-05-09

Application Sponsors

NDA 050574NOVARTIS

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL100MG/ML1SANDIMMUNECYCLOSPORINE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1983-11-14PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1993-02-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1993-02-24PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1991-03-14PRIORITY
LABELING; LabelingSUPPL6AP1991-06-10
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1992-02-21PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1993-02-11PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1993-03-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1994-05-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1994-05-09PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1994-05-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1995-03-07PRIORITY
LABELING; LabelingSUPPL15AP1994-11-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1995-04-28PRIORITY
LABELING; LabelingSUPPL17AP1995-11-21STANDARD
LABELING; LabelingSUPPL18AP1996-08-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1996-03-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1998-03-30PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1998-01-30PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1998-07-27PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1998-10-20PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL24AP1999-05-13PRIORITY
LABELING; LabelingSUPPL25AP2000-10-04STANDARD
LABELING; LabelingSUPPL26AP1999-12-21STANDARD
LABELING; LabelingSUPPL27AP2003-02-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2001-11-16PRIORITY
LABELING; LabelingSUPPL29AP2003-02-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL30AP2002-02-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL31AP2002-01-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL32AP2002-06-14PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL33AP2002-04-12PRIORITY
LABELING; LabelingSUPPL35AP2004-02-06STANDARD
LABELING; LabelingSUPPL37AP2004-02-06STANDARD
LABELING; LabelingSUPPL39AP2005-07-19STANDARD
LABELING; LabelingSUPPL40AP2006-03-06STANDARD
LABELING; LabelingSUPPL41AP2009-10-08UNKNOWN
LABELING; LabelingSUPPL42AP2010-04-30UNKNOWN
LABELING; LabelingSUPPL43AP2012-08-30STANDARD
LABELING; LabelingSUPPL47AP2013-05-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL49AP2014-01-22PRIORITY
LABELING; LabelingSUPPL51AP2015-03-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL52AP2016-07-14PRIORITY

Submissions Property Types

SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL16Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL28Null0
SUPPL30Null0
SUPPL31Null0
SUPPL32Null0
SUPPL33Null0
SUPPL41Null6
SUPPL42Null6
SUPPL43Null6
SUPPL47Null7
SUPPL49Null0
SUPPL51Null15
SUPPL52Null0

TE Codes

001PrescriptionAB2

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50574
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.